Stay updated on Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Sign up to get notified when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:34:01.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0. This appears to be a metadata/site version change with no visible impact on the study details.
    Difference
    0.0%
    Check dated 2026-03-19T19:09:07.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3 and the previous v3.4.2 entry was removed.
    Difference
    0.0%
    Check dated 2026-03-12T15:15:09.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older notices including the government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T20:33:51.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and system status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:50:56.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    A glossary toggle has been added to the page to improve terms accessibility. Metadata headers were updated to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision version is now v3.4.0 (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T06:34:16.000Z thumbnail image

Stay in the know with updates to Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.